Data base for:
Register for free and add any data by yourself!
Global pharmaceutical R and D spend is increasing rapidly, now topping a staggering $238bn globally. Increased spend, coupled with unpredictable inflation-related price increases and urgency to fast-track breakthroughs in exciting modalities to market means more pressure on procurement to deliver than ever before. To create much needed visibility on how to combat against mounting risk facing supply and optimize spend, the 7th R and D Sourcing and Procurement in Pharma Summit returns to Boston this May. As the dependable platform uniting 120+ Procurement, Sourcing, Category Management and Clinical Operations personnel, providing the knowledge and networking necessary to stay at the forefront of technology and tactics to drive proactivity, sustainability and profitability in your procurement operations. As we expand the meeting to two tracks dedicated to Discovery and Preclinical and Clinical procurement, in 2023 you're more comprehensively than ever before gaining intelligence necessary to inform your pipeline's purchasing strategy. Your Unmissable Highlights for 2023: Build risk mitigation into supply chains with the pre-identification of bottlenecks to ensure timely allocation of R and D materials in-budget with NovartisScale promising cell and gene therapy pipelines to GMP and beyond with compliancy in mind with Atrara Biotherapeutics and Lexeo TherapeuticsDrive efficiencies in early R and D with cost containment and anticipating the needs of scientists to deliver fast-paced programs with Astellas Pharma and Editas MedicineEstablish and maintain robust clinical partnerships with the design of supplier selection metrics and measurement criteria with I-Mab BioPharma and GSKExpedite R and D through AI and predictive analytics which drive higher success rates in scientific programs with Takeda and UCB URLs:Tickets: https://go.evvnt.com/1594472-2?pid=5569 Brochure: https://go.evvnt.com/1594472-3?pid=5569 Date and Time: On Tue, May 30, 23 ( 9:30 AM) - Thu, Jun 1, 23 ( 4:30 PM) Venue details: The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States Prices:Pharma and Biotech - Conference + 3 Workshops: USD 4096.00,Pharma and Biotech - Conference + 2 Workshops: USD 3597.00,Pharma and Biotech - Conference + 1 Workshop: USD 3098.00,Pharma and Biotech - Conference Only: USD 2599.00,Solution Providers - Conference + 3 Workshops: USD 6046.00,Solution Providers - Conference + 2 Workshops: USD 5297.00,Solution Providers - Conference + 1 Workshop: USD 4548.00,Solution Providers - Conference Only: USD 3799.00 Speakers: Aaron Nolan Associate Director, Clinical Laboratory Sciences, Eli Lilly and Co., Alan Salter, Director - Clinical Partner Management, Takeda Pharmaceutical Co. Ltd., Amber Meriwether, Director - Research, Development, Procurement and Global Category Lead, Astellas Innovation Management LLC, Amit Joshi Director, Strategic Sourcing, Iovance, Anca Copaescu, Chief Executive Officer, Clinical Maestro, Andrew Nation, Associate Director - Sourcing Excellence Research and Development, Bristol Myers Squibb, Andrew Petterelli, Category Management Manager, Regeneron Pharmaceuticals Inc, Ann Shrouder, Senior Director of Strategic Sourcing and Procurement, Aurinia Pharmaceuticals, Anthony Fuller, Global Head of Sourcing , Mitsubishi Tanabe Pharma, Daniel Kagan, Customer Success Manager, Scientist, David Garza, Sr. Director, Global R and D Procurement, Eli Lilly and Co., Diane Fortune Senior Director, Strategic Procurement, Travere Therapeutics, Inc., Dillon Tagle, Director - Research and Development, Procurement, Clinical Labs and Diagnostics, GlaxoSmithKline Plc, Gerard Cardillo, Vice President, Global Procurement, Charles River Laboratories, Heng Liu, Global Procurement, I-mab Biopharma, Isaac Rodriguez-Chavez, Independent Consultant, former ICON plc and former FDA Official, James Murphy, Senior Category Manager, BioMarin Pharmaceutical, James Tornos, Vice President - Sourcing, Enterprise Services, Research, Development and Medical Procurement, Pfizer, Jiali Chen, Senior Director, Head of Procurement, Scorpion Therapeutics, Keisha Mitchell, Associate Director, Procurement, Gilead Sciences, Kent Walker, Senior Strategic Sourcing Leader, Biogen Idec, Kristen Mitchell, Head of Procurement, Editas Medicine, Marta Bialkowska, Head of Procurement Early Research, UCB S.A., Michael Serghiou Senior Director, Global Head of Discovery Research Procurement, Takeda, Mike Knievel, Senior Director, Procurement, Gilead, Raj Joshi, Head Of Sourcing and Procurement, Celularity, Rinaldo Dorman, Associate Director - Clinical Procurement, Sarepta Therapeutics, Sarah Brody-Kaplan, Director - Alliance and Partnerships, Genentech Inc, Seth Dunn, Director, Procurement Operations and P2P, Eisai, Siamak Baharloo, Chief Executive Officer and Co-Founder, Labviva LLC, Suman Purumandla, Global Strategic Sourcing - R and D, Novavax, Vincent Turula, Senior Director, Lexeo Therapeutics, Zulma Janeth Garcia, Olmedo Associate Director, Global Procurement Partner, R and D, Novartis